Furthermore, in obese individuals with sleep disorders, the secretion and activity of GLP-1 RA are decreased, which can lead to abnormal sugar metabolism and weight gain, thereby exacerbating OSA [63, 77, 78]
False sense of security: Relying on ineffective patches can delay individuals from seeking actual, evidence-based medical care for weight management, allowing underlying health issues to persist or worsen
Minimizing Risks: Medication Safety and Side Effects RMWL utilizes a PCAB-accredited pharmacy, ensuring compounded medications meet safety standards
GLP-1 medications were initially developed to treat diabetes but have recently gained widespread recognition for their significant effectiveness in promoting weight loss
The result is a body that burns fewer calories and sends stronger hunger signals